THE ESSENTIAL ROLE OF GLUCAGON IN THE PATHOGENESIS OF DIABETES MELLITUS
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The following evidence suggests that diabetes mellitus may not be the simple consequence of relative or absolute insulin deficiency by itself, but may require the presence of glucagon: (1) relative or absolute hyperglucogonaemia has been identified in every form of endogenous hyperglycaemia, including total pancreatectomy in dogs; (2) insulin lack in the absence of glucagon does not cause endogenous hyperglycaemia, but when endogenous or exogenous glucagon is present, it quickly appears, irrespective of insulin levels at the time. These facts are compatible with a bihormonal-abnormality hypothesis, which holds that the major consequence of absolute or relative insulin lack is glucose underutilisation and that absolute or relative glucagon excess is the principal factor in the over-production of glucose in diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Glucagon, traditionally known for its ability to counteract hypoglycemia, has been implicated in the pathogenesis of type 1 and type 2 diabetes12-14 (Textbox).”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [12]
Citations
Cites
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
Brazeau, P., Vale, W., Burgus, R., Ling, N., Butcher, M., Rivier, J., & Guillemin, R. (1973) · Science · doi:10.1126/science.179.4068.77 · Cited by 3,532
Studies of pancreatic alpha cell function in normal and diabetic subjects
Unger, R. H., Aguilar-Parada, E., Müller, W. A., & Eisentraut, A. M. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106297 · Cited by 837
Self-citationThe internal secretion of the pancreas
Banting, F., & BEST, C. H. (1922) · Journal of Laboratory and Clinical Medicine · doi:10.5555/uri:pii:s0022214322903841 · Cited by 784
Abnormal Alpha-Cell Function in Diabetes: Response to Carbohydrate and Protein Ingestion
Müller, W. A., Faloona, G. R., Aguilar-Parada, E., & Unger, R. H. (1970) · New England Journal of Medicine · doi:10.1056/nejm197007162830301 · Cited by 626
Self-citationPancreatic Glucagon Secretion in Normal and Diabetic Subjects
Aguilar-Parada, E., Eisentraut, A. M., & Unger, R. H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00008 · Cited by 535
Self-citationSomatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas
Koerker, D. J., Ruch, W., Chideckel, E., Palmer, J., Goodner, C. J., Ensinck, J., & Gale, C. C. (1974) · Science · doi:10.1126/science.184.4135.482 · Cited by 519
Diabetes mellitus nach Pankreasexstirpation
Mering, J., & Minkowski, O. (1890) · Archiv für Experimentelle Pathologie und Pharmakologie · doi:10.1007/bf01831214 · Cited by 480
INHIBITION OF INSULIN SECRETION BY SOMATOSTATIN
Alberti, K. G. M. M., Juel Christensen, N., Engkjær Christensen, S., Prange Hansen, A., Iversen, J., Lundbæk, K., Seyer-Hansen, K., & Ørskov, H. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92873-0 · Cited by 457
Mortimer, C. H., Carr, D., Lind, T., Bloom, S. R., Mallinson, C. N., Schally, A. V., Tunbridge, W. M. G., Yeomans, L., Coy, D. H., Kastin, A., et al. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92903-1 · Cited by 268
Gerich, J. E., Lorenzi, M., Schneider, V., Karam, J. H., Rivier, J., Guillemin, R., & Forsham, P. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197409122911102 · Cited by 239
Effects of Glucagon on Lipolysis and Ketogenesis in Normal and Diabetic Men
Liljenquist, J. E., Bomboy, J. D., Lewis, S. B., Sinclair-Smith, B. C., Felts, P. W., Lacy, W. W., Crofford, O. B., & Liddle, G. W. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107537 · Cited by 147
Wilmore, D. W., Moylan, J. A., Pruitt, B., Lindsey, C. A., Faloona, G. R., & Unger, R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92290-9 · Cited by 146
Self-citationControl of Pancreatic Glucagon Secretion by Glucose
Ohneda, A., Aguilar-Parada, E., Eisentraut, A. M., & Unger, R. H. (1969) · Diabetes · doi:10.2337/diab.18.1.1 · Cited by 127
Self-citationGLUCAGON CONTROL OF FASTING GLUCOSE IN MAN
ALFORD, F. P., Bloom, S. R., Nabarro, J. D. N., Hall, R., BESSER, G. M., Coy, D. H., Kastin, A. J., & Schally, A. V. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92071-6 · Cited by 126
Somatostatin-Induced Changes in Insulin and Glucagon Secretion in Normal and Diabetic Dogs
Sakurai, H., DOBBS, R. E., & Unger, R. H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107886 · Cited by 120
Self-citationPancreatic alpha-cell function in trauma
Lindsey, A., Santeusanio, F., Braaten, J., Faloona, G. R., & Unger, R. H. (1974) · JAMA · doi:10.1001/jama.227.7.757 · Cited by 119
Self-citationAntagonism Between the Effects of Insulin and Glucagon on the Isolated Liver
Mackrell, D. J., & Sokal, J. E. (1969) · Diabetes · doi:10.2337/diab.18.11.724 · Cited by 118
Pancreatic alpha-cell function in trauma.
Lindsey, A., Santeusanio, F., Braaten, J. T., et al. (1974) · PubMed · Cited by 110
Madison, L. L., Combes, B., Adams, R. H., & Strickland, W. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104065 · Cited by 104
ABNORMALITIES OF GLUCAGON METABOLISM IN UNTREATED DIABETES MELLITUS
Buchanan, K. D., & Mccarroll, A. M. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92964-9 · Cited by 97
Influence of glucagon and 3', 5'-AMP on insulin responsiveness of the perfused rat liver
Glinsmann, W. H., & Mortimore, G. E. (1968) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1968.215.3.553 · Cited by 97
Abnormal Alpha Cell Function in Diabetics Response to Insulin
Unger, R. H., Madison, L. L., & Müller, W. A. (1972) · Diabetes · doi:10.2337/diab.21.5.301 · Cited by 89
Self-citationPancreatic Alpha-Cell Function in Trauma
Lindsey, A. (1974) · JAMA · doi:10.1001/jama.1974.03230200015003 · Cited by 78
AMHERDT, M., Harris, V., Renold, A. E., Orci, L., & Unger, R. H. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107742 · Cited by 72
Self-citationWillerson, J. T., Hutcheson, D. R., Leshin, S. J., Faloona, G. R., & Unger, R. H. (1974) · The American Journal of Medicine · doi:10.1016/0002-9343(74)90848-1 · Cited by 68
Self-citationFrankel, B. J., Gerich, J. E., Hagura, R., Fanska, R. E., Gerritsen, G. C., & Grodsky, G. M. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107714 · Cited by 68
Studies of the development of diabetic ketosis in the rat
Meier, J. M., McGarry, J. D., Faloona, G. R., Unger, R. H., & Foster, D. W. (1972) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39416-5 · Cited by 55
Self-citationAction of Streptozotocin on Insulin and Glucagon Responses of Rat Islets
Katsilambros, N., Rahman, Y., Hinz, M., Fußgänger, R., Schröder, K., Straub, K., & Pfeiffer, E. (1970) · Hormone and Metabolic Research · doi:10.1055/s-0028-1095056 · Cited by 40
Tenth Annual Meeting of the European Association for the Study of Diabetes
Alberti, K. G. M. M., Iversen, J., Christensen, N. J., Andersson, A., Jarrousse, C., Andersson, A., Hellerström, C., Andreani, D., TAMBURRANO, G., Tamburrano, S., et al. (1974) · Diabetologia · doi:10.1007/bf02627739 · Cited by 7
Research works printed but not linked: 8
- Banting, 1922, J. Lab. clin. Med., 7, 251
- Muller, 1971, J. clin. Invest., 50
- C.A. Lindsey, G.R. Faloona, R.H. Unger, Diabetes ((in the press)).
- Matsuyama, 1974, Diabetes, 23, 344
- G.D. Mashiter, P.E. Harding, M. Chou, J. Stout, D. Diamond, J.B. Field, Endocrinology ((in the press)).
- R.E. Dobbs, H. Sakurai, H. Sasaki, G.R. Faloona, I. Valverde, D. Baetens, L. Orci, R.H. Unger, Science ((in the press)).
- Goodner, 1974, J. clin. Invest., 53, 28
- Dobbs, 1974, Clin. Res., 22, 648A
Cited by
Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes
Lyssenko, V., Lupi, R., Marchetti, P., Del Guerra, S., Orho-Melander, M., Almgren, P., Sjögren, M., Ling, C., Eriksson, K.-F., Lethagen, Υ.-L., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30706 · Cited by 829
Pancreatic β‐cell mass in European subjects with type 2 diabetes
Rahier, J., Guiot, Y., Goebbels, R. M., Sempoux, C., & Henquin, J. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00969.x · Cited by 756
“This relative hyperglucagonaemia aggravates the consequences of their relative hypoinsulinaemia by activating glucose production in the liver [8–10].”
Backgroundβ-Cell Failure in Diabetes and Preservation by Clinical Treatment
Wajchenberg, B. L. (2007) · Endocrine Reviews · doi:10.1210/10.1210/er.2006-0038 · Cited by 714
Glucagonocentric restructuring of diabetes: A pathophysiologic and therapeutic makeover
Unger, R. H., & Cherrington, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60016 · Cited by 670
Self-citationα-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Metadata
- Authors
- Unger, R., & Orci, L.
- Affiliations
- Dallas VA Medical Center (US)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1975-01
- Volume
- 305
- Issue
- 7897
- Pages
- 14-16
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2010787940
- Cited by
- 599
- References
- 28
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 17 · 2023: 26 · 2022: 20 · 2021: 26 · 2020: 20 · 2019: 16 · 2018: 21 · 2017: 16 · 2016: 12 · 2015: 19 · 2014: 24 · 2013: 13 · 2012: 14
- FWCI
- 96.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- glucagon, diabetes pathogenesis, hyperglucagonaemia, insulin deficiency, total pancreatectomy
- MeSH terms
- Insulin Secretion, Alanine, Animals, Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Experimental, Dogs, Glucagon, Glucose, Humans, Hyperglycemia, Insulin, Islets of Langerhans, Liver, Pancreatectomy, Growth Hormone-Releasing Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.